作者
Shira Weingarten-Gabbay,Susan Klaeger,Siranush Sarkizova,Leah R. Pearlman,Da Yuan Chen,Kathleen M.E. Gallagher,Matthew R. Bauer,Hannah B. Taylor,Walter Dunn,Christina Tarr,John Sidney,Suzanna Rachimi,Hasahn L Conway,Katelin Katsis,Yuntong Wang,Del Leistritz-Edwards,Melissa Durkin,Christopher H. Tomkins-Tinch,Yaara Finkel,Aharon Nachshon,Matteo Gentili,Keith Rivera,Isabel Carulli,Vipheaviny Chea,Abishek Chandrashekar,Cansu Cimen Bozkus,Mary Carrington,Kendall M. Lavin-Parsons,Blair A. Parry,Brendan M. Lilley,Carl L. Lodenstein,Brenna McKaig,Nicole C. Charland,Hargun K. Khanna,Justin D. Margolin,Anna L.K. Gonye,Irena Gushterova,Thomas J. LaSalle,Nihaarika Sharma,Brian C. Russo,Maricarmen Rojas-López,Moshe Sade-Feldman,Kasidet Manakongtreecheep,Jessica Tantivit,Molly Thomas,Nina Bhardwaj,Dan H. Barouch,Alessandro Sette,Marcela V. Maus,Charles M. Rice,Karl R. Clauser,Derin B. Keskin,Daniel C. Pregibon,Nir Hacohen,Steven A. Carr,Jennifer G. Abelin,Mohsan Saeed,Pardis C. Sabeti
摘要
T cell-mediated immunity plays an important role in controlling SARS-CoV-2 infection, but the repertoire of naturally processed and presented viral epitopes on class I human leukocyte antigen (HLA-I) remains uncharacterized. Here, we report the first HLA-I immunopeptidome of SARS-CoV-2 in two cell lines at different times post infection using mass spectrometry. We found HLA-I peptides derived not only from canonical open reading frames (ORFs) but also from internal out-of-frame ORFs in spike and nucleocapsid not captured by current vaccines. Some peptides from out-of-frame ORFs elicited T cell responses in a humanized mouse model and individuals with COVID-19 that exceeded responses to canonical peptides, including some of the strongest epitopes reported to date. Whole-proteome analysis of infected cells revealed that early expressed viral proteins contribute more to HLA-I presentation and immunogenicity. These biological insights, as well as the discovery of out-of-frame ORF epitopes, will facilitate selection of peptides for immune monitoring and vaccine development.